FDA 483 - D'Alessandro, Anthony M. - June 18, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Dr. Anthony M. D'Alessandro, a clinical investigator in Madison, WI, revealed significant deficiencies in the conduct of the OrganOx WP01 clinical research study. The firm failed to maintain accurate, complete, and current subject case histories and source documents, and did not properly manage or report protocol deviations. Additionally, the investigational device was not maintained according to the agreed-upon plan, leading to its use past its maintenance due date.
ID · 319caf52-1c7d-466d-aed9-b3eb301df7b4